UltraShort Health Care
ProShares UltraShort Health Care seeks daily investment results, before fees and expenses, that correspond to twice (200%) the inverse (opposite) of the daily performance of the Dow Jones U.S. Health Care IndexSM.
Product Menu:
Index/Benchmark Summary
The Dow Jones U.S. Health Care Index measures the performance of the health care economic sector of the U.S. equity market. Component companies include health care providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.
As of 3/31/12
Fundamentals
| Total Number of Companies |
Price/Earnings Ratio |
Price/Book Ratio |
Dividend Yield * (%) |
Average Index Market Capitalization |
|---|---|---|---|---|
| 120 | 12.56 | 2.88 | 2.04 | $13.29 billion |
* Derivative contracts are priced to reflect the underlying index yield and will not generate dividend income. Because ProShares invest in derivatives, they will not have dividend distributions that reflect those of their applicable indexes.
| Top 10 Index Companies ‡ | Weight |
|---|---|
| Johnson & Johnson | 11.31% |
| Pfizer Inc. | 10.92% |
| Merck & Co. Inc. | 7.40% |
| Abbott Laboratories | 5.98% |
| UnitedHealth Group Inc. | 3.98% |
| Amgen Inc. | 3.74% |
| Bristol-Myers Squibb Co. | 3.63% |
| Medtronic Inc. | 2.61% |
| Eli Lilly & Co. | 2.48% |
| Gilead Sciences Inc. | 2.30% |
‡ ProShares may invest in financial instruments (including derivatives) that, in combination, should have similar daily price return characteristics to the fund's benchmark.
| Index Sector Weightings § | Weight |
|---|---|
| Pharmaceuticals & Biotechnology | 63.48% |
| Health Care Equipment & Services | 36.52% |
§ Sum of weightings may not equal 100% due to rounding.